Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
- 9 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 184 (1) , 1-14
Abstract
Quantification of variation in levels of spontaneously occurring cancer driver mutations (CDMs) was developed to assess clonal expansion and predict future risk of neoplasm development. Specifically, an error-corrected next-generation sequencing method, CarcSeq, and a mouse CarcSeq panel (analogous to human and rat panels) were developed and used to quantify low-frequency mutations in a panel of amplicons enriched in hotspot CDMs. Mutations in a subset of panel amplicons, Braf, Egfr, Kras, Stk11, and Tp53, were related to incidence of lung neoplasms at 2 years. This was achieved by correlating median absolute deviation (MAD) from the overall median mutant fraction (MF) measured in the lung DNA of 16-week-old male and female, B6C3F1 and CD-1 mice (10 mice/sex/strain) with percentages of spontaneous alveolar/bronchioloalveolar adenomas and carcinomas reported in bioassay control groups. A total of 1586 mouse lung mutants with MFs >1 × 10−4 were recovered. The ratio of nonsynonymous to synonymous mutations was used to assess the proportion of recovered mutations conferring a positive selective advantage. The greatest ratio was observed in what is considered the most lung tumor-sensitive model examined, male B6C3F1 mice. Of the recurrent, nonsynonymous mouse mutations recovered, 55.5% have been reported in human tumors, with many located in or around the mouse equivalent of human cancer hotspot codons. MAD for the same subset of amplicons measured in normal human lung DNA samples showed a correlation of moderate strength and borderline significance with age (a cancer risk factor), as well as age-related cumulative lung cancer risk, suggesting MAD may inform species extrapolation.Keywords
Funding Information
- U.S. Food and Drug Administration
- National Center for Toxicological Research
- Center for Drug Evaluation Research
- ORISE Research Participation Program
- NCTR
- U.S. Department of Energy
- FDA
- NCTR
This publication has 37 references indexed in Scilit:
- Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of CarcinogenesisEnvironmental Health Perspectives, 2016
- High burden and pervasive positive selection of somatic mutations in normal human skinScience, 2015
- Low-Frequency Kras Mutations are Prevalent in Lung AdenocarcinomasPersonalized Medicine, 2015
- Age and Cancer RiskAmerican Journal of Preventive Medicine, 2014
- Gender differences in the incidence of background and chemically induced primary pulmonary neoplasms in B6C3F1 mice: A retrospective analysis of the National Toxicology Program (NTP) carcinogenicity bioassaysExperimental and Toxicologic Pathology, 2013
- Incidence of Spontaneous Non-Neoplastic Lesions in Transgenic CBYB6F1-Tg(HRAS)2Jic MiceToxicologic Pathology, 2013
- A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroidMolecular Carcinogenesis, 2012
- Differential Transcriptomic Analysis of Spontaneous Lung Tumors in B6C3F1 Mice: Comparison to Human Non–Small Cell Lung CancerToxicologic Pathology, 2012
- ACB-PCR Quantification of K-RASCodon 12 GAT and GTT Mutant Fraction in Colon Tumor and Non-Tumor TissueCancer Investigation, 2010
- Carcinogenicity Evaluation: Comparison of Tumor Data from Dual Control Groups in the CD–1 MouseToxicologic Pathology, 2007